“I’m guessing part of the thing is in relation to funding, but it’s also important to recognise – sometimes you have to actually look at something and say ‘this is something that is going to help save money for both the health system, and also deliver the best possible care for cancer patients’ – surely that’s a win-win situation?
Trending
- Merseyside lung cancer patient first in world to get new vaccine
- SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma
- Relapsed childhood cancers show genomic scars left by previous therapy
- Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma
- Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer
- Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma
- SETD8-mediated mono-methylation of YAP at K76 promotes K48-linked polyubiquitination and degradation to suppress colorectal cancer
- Weighing the Catabolic Effects of Lenvatinib/Everolimus vs SOC in ccRCC
Thursday, July 30
